"
Team:Westminster
From 2012.igem.org
| Line 126: | Line 126: | ||
height: 40px; | height: 40px; | ||
line-height: 40px; | line-height: 40px; | ||
| - | background: #ffb35a url( | + | background: #ffb35a url(https://static.igem.org/mediawiki/igem.org/8/8b/Topbg.gif) repeat-x; |
border-bottom: 1px solid #000; | border-bottom: 1px solid #000; | ||
} | } | ||
| Line 137: | Line 137: | ||
#menu ul li.hasmore | #menu ul li.hasmore | ||
{ | { | ||
| - | background: url( | + | background: url(https://static.igem.org/mediawiki/igem.org/c/c8/Drophighlight.png) no-repeat center 27px; |
} | } | ||
| Line 166: | Line 166: | ||
#menu ul li a:hover | #menu ul li a:hover | ||
{ | { | ||
| - | background: url(../ | + | background: url(https://static.igem.org/mediawiki/igem.org/c/c1/Topselectionleft.png) top left no-repeat; |
} | } | ||
| Line 177: | Line 177: | ||
#menu ul li a:hover span | #menu ul li a:hover span | ||
{ | { | ||
| - | background: url(../ | + | background: url(https://static.igem.org/mediawiki/igem.org/4/49/Topselectionright.png) top right; |
} | } | ||
| Line 183: | Line 183: | ||
{ | { | ||
padding: 10px; | padding: 10px; | ||
| - | background-image: url(../ | + | background-image: url(https://static.igem.org/mediawiki/igem.org/9/9e/Dropdown.png); |
overflow:hidden; | overflow:hidden; | ||
border-bottom: 1px solid #37dc2f; | border-bottom: 1px solid #37dc2f; | ||
| Line 204: | Line 204: | ||
#menu ul.dropdown li a:hover | #menu ul.dropdown li a:hover | ||
{ | { | ||
| - | background: url(../ | + | background: url(https://static.igem.org/mediawiki/igem.org/e/e7/Menuarrow.png) no-repeat left center; |
} | } | ||
Revision as of 21:23, 14 September 2012
| You can write a wiki of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. |  |
|
We have created a genetically engineered machine to identify, isolate and eliminate Cancer Stem Cells (CSCs). According to the latest Cancer Stem Cell Theory, not all the cancer cells have the same ability to generate new tumors. Tumor growth is mostly driven by a small proportion of cells, the CSCs. In addition to having high proliferation rates, CSCs are more resistant to chemotherapy. This indicates that while regular cancer cells are killed, CSCs may remain unaffected and give rise to new tumors once the treatment stops. CSCs produce increased levels of a particular enzyme, Aldehyde Dehydrogenase. We have identified its 3 most frequent isoforms (ALDH1A1, ALDH1A3 and ALDH3A1)in aggressive types of cancer, and used their gene promoters to build our CSC-targeting constructs: the iSTEM -Intelligent Synthetic Tumor Eliminating Machine. |  The team |
| Team Westminster |
